by Rachel Montague | Mar 2, 2021 | Source news
Watch the recording It can be challenging to develop an economic model in rare diseases that optimises HTA and reimbursement outcomes. It can be difficult to fully capture the effects of the disease and the benefits of treatment whilst using sufficiently robust data...
by Rachel Montague | Nov 2, 2018 | Source news
Written by Juliet Mumby-Croft, Director Project HERCULES is a unique international multi-stakeholder collaborative project set up by Duchenne UK to develop tools and evidence to support Health Technology Assessment (HTA) and reimbursement decisions for new treatments...
